Related references
Note: Only part of the references are listed.Metformin Protects Endothelial Function in Diet-Induced Obese Mice by Inhibition of Endoplasmic Reticulum Stress Through 5' Adenosine Monophosphate-Activated Protein Kinase-Peroxisome Proliferator-Activated Receptor δ Pathway
Wai San Cheang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation
Wei-dong Qin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
Jie Hong et al.
DIABETES CARE (2013)
AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6
Brendan Gongol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension
Naoko Deji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Poly(ADP-Ribose) Polymerase 1 Inhibition Improves Coronary Arteriole Function in Type 2 Diabetes Mellitus
Soo-Kyoung Choi et al.
HYPERTENSION (2012)
Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome
Takuya Kishi et al.
JOURNAL OF HYPERTENSION (2012)
REPRODUCTIVE ENDOCRINOLOGY Infertility treatment in PCOS-is metformin in from the cold?
Evanthia Diamanti-Kandarakis
NATURE REVIEWS ENDOCRINOLOGY (2012)
Telmisartan Exerts Antiatherosclerotic Effects by Activating Peroxisome Proliferator-Activated Receptor-γ in Macrophages
Takeshi Matsumura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase
Chi Yung Yuen et al.
CARDIOVASCULAR RESEARCH (2011)
PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
Peter Bai et al.
CELL METABOLISM (2011)
AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study
J. G. Boyle et al.
DIABETOLOGIA (2011)
Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress A new mechanism for the cytoplasmic effect of PARP-1 activation
Boglarka Racz et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats
Minoru Satoh et al.
HYPERTENSION RESEARCH (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
Activation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells
Beate Fisslthaler et al.
CIRCULATION RESEARCH (2009)
Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE-/- Mice: Effects on eNOS and Oxidative Stress
Chetan P. Hans et al.
PLOS ONE (2009)
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease
Pal Pacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat
Vijay Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2
Marlene T. Mathews et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Metformin improves endothelial function in normoinsulinemic PCOS patients:: a new prospective
D. Romualdi et al.
HUMAN REPRODUCTION (2008)
Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system -: Role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor γ signaling during endothelial aging
Fortunato Scalera et al.
HYPERTENSION (2008)
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
PARP1 is required for adhesion molecule expression in atherogenesis
Tobias von Lukowicz et al.
CARDIOVASCULAR RESEARCH (2008)
Telmisartan improves endothelial function in patients with essential hypertension
Ralf A. Benndorf et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Poly-(ADP-ribose) polymerase-1 (Parp-1) binds in a sequence-specific manner at the Bcl-6 locus and contributes to the regulation of Bcl-6 transcription
H. E. Ambrose et al.
ONCOGENE (2007)
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice -: Effects on macrophage recruitment, nuclear factor-κB nuclear translocation, and foam cell death
Karine Oumouna-Benachour et al.
CIRCULATION (2007)
ATI receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans
Jeremy Bellien et al.
CLINICAL SCIENCE (2007)
DNA-independent PARP-1 activation by phosphorylated ERK2 increases EIk1 activity: A link to histone acetylation
Malka Cohen-Armon et al.
MOLECULAR CELL (2007)
Statins activate AMP-activated protein kinase in vitro and in vivo
Wei Sun et al.
CIRCULATION (2006)
Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2
TM Kauppinen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance
LGK De Acular et al.
DIABETES CARE (2006)
Protection against oxidative stress in diabetic rats:: Role of angiotensin AT1 receptor and beta 1-adrenoceptor antagonism
M Dorenkamp et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
P Jagtap et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Metformin and vascular protection: a cardiologist's view
P Libby
DIABETES & METABOLISM (2003)
Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts
TL Andreone et al.
JOURNAL OF IMMUNOLOGY (2003)
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes
P Pacher et al.
DIABETES (2002)
Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function
EL Schiffrin et al.
JOURNAL OF HYPERTENSION (2002)
Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells - Inhibition by the AMP-activated protein kinase activation
Y Ido et al.
DIABETES (2002)
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase
FG Soriano et al.
CIRCULATION RESEARCH (2001)
Improved endothelial function with metformin in type 2 diabetes mellitus
KJ Mather et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Polycystic ovary syndrome is associated with endothelial dysfunction
G Paradisi et al.
CIRCULATION (2001)
A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: A multicenter study
Y Higashi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
